Germline DNAs were genotyped using a custom panel of 86 preselected immunogenetically related genes in 94 consecutive patients with advanced cancer treated with anti-PD-1/PD-L1 checkpoint inhibitors. The gene discussed is PDCD1; the disease is cancer.